Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard Wennekamp Insider Profile
4 Followers
Richard Wennekamp, Director at CytRx, holds 116.97K shares in CytRx (Ticker: CYTR). Most recently, Richard Wennekamp Bought $111,965 shares of CytRx on Feb 23, 2012 for an estimated value of 35.08K.
Richard Wennekamp has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Richard Wennekamp's holdings
Insider Roles
Director
Roles that Richard Wennekamp holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Richard Wennekamp
Richard Wennekamp's Trading History
List of latest transactions for each holding click on a transaction to see Richard Wennekamp's performance on stock
You May Also Like
Richard Wennekamp insider profile FAQ
What is the percentage of profitable transactions made by Richard Wennekamp?
The percentage of profitable transactions made by Richard Wennekamp is ―.
What is the average return per transaction made by Richard Wennekamp?
The average return per transaction made by Richard Wennekamp is ―.
What stocks does Richard Wennekamp hold?
Richard Wennekamp holds: CYTR stocks.
What was Richard Wennekamp’s latest transaction?
Richard Wennekamp latest transaction was an Informative Buy of $35.08K.
What was Richard Wennekamp's most profitable transaction?
Richard Wennekamp’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Richard Wennekamp's role in CytRx?
Richard Wennekamp's role in CytRx is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.